A Multicentre, Randomised, Open-Label, Prospective Study to Estimate the Add-On Effects Of Memantine as Ebixa(®) Oral Pump (Solution) on Language in Patients with Moderate to Severe Alzheimer’s Disease Already Receiving Donepezil (ROMEO-AD)

INTRODUCTION: This multicentre, randomised, open-label, and prospective study aimed to evaluate the effectiveness of memantine (memantine solution) on speech function in patients with moderate to severe Alzheimer’s disease (AD) who were already on donepezil therapy. METHODS: Participants were divide...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hee-Jin, Shim, YongSoo, Han, Hyun Jeong, Kim, Byeong C., Park, Kee Hyung, Moon, So Young, Choi, Seong Hye, Yang, Dong Won, Yoon, Bora, Kim, Eun-Joo, Jeong, Jee Hyang, Han, Seol-Heui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310610/
https://www.ncbi.nlm.nih.gov/pubmed/37245175
http://dx.doi.org/10.1007/s40120-023-00494-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310610/
https://www.ncbi.nlm.nih.gov/pubmed/37245175
http://dx.doi.org/10.1007/s40120-023-00494-5

Ejemplares similares